Digestive Diseases and Sciences

, Volume 57, Issue 6, pp 1636–1646

Comprehensive Self-Management Reduces the Negative Impact of Irritable Bowel Syndrome Symptoms on Sexual Functioning

  • Margaret D. Eugenio
  • Sang-Eun Jun
  • Kevin C. Cain
  • Monica E. Jarrett
  • Margaret M. Heitkemper
Original Article
  • 238 Downloads

Abstract

Background

Women with irritable bowel syndrome (IBS) report sexual dysfunction. Comprehensive self-management (CSM) intervention has been shown to reduce gastrointestinal, psychological, and somatic symptoms in IBS women. Whether this intervention also reduces sexual dysfunction is not known.

Aims

We sought to compare demographic and clinical factors in IBS women with and without sexual dysfunction as defined by the Arizona sexual experiences scale (ASEX) and to test the effects of CSM treatment on sexual dysfunction scores and on the sexual relations subscale of an IBS quality of life (IBSQOL) scale which measures the effect of IBS on sexual QOL.

Methods

IBS (Rome II) women enrolled in a randomized clinical trial of CSM treatment were characterized as having sexual dysfunction (N = 89) or not (N = 86) at baseline based on ASEX criteria. Baseline characteristics and symptoms were compared between the two groups. Post-intervention changes were compared between the CSM and the usual care arms of the randomized trial.

Results

Women meeting ASEX criteria for sexual dysfunction were older, had higher lifetime depression and antidepressant use, more primary care/MD visits, fewer mental healthcare visits, and greater sleep disturbance than those without sexual dysfunction. No significant group differences in gastrointestinal or somatic symptoms were observed. Compared with usual care treatment, CSM increased sexual QOL scores and had a weaker effect on ASEX scores.

Conclusions

Severity of IBS symptoms at baseline did not differ between IBS women with or without sexual dysfunction. The CSM intervention can reduce the effect of IBS on sexual QOL.

Keywords

Arizona Sexual Experiences Scale Irritable bowel syndrome Sexual dysfunction Women 

Abbreviations

ASEX

Arizona Sexual Experiences Scale

CSM

Comprehensive self-management

IBS

Irritable bowel syndrome

NSexD

No sexual dysfunction group

QOL

Quality of life

SexD

Sexual dysfunction group

SSRI

Selective serotonin reuptake inhibitors

References

  1. 1.
    Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in north america. Am J Gastroenterol. 2002;97:S7–S26.PubMedGoogle Scholar
  2. 2.
    Fass R, Fullerton S, Naliboff B, Hirsh T, Mayer EA. Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion. 1998;59:79–85.PubMedCrossRefGoogle Scholar
  3. 3.
    Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in united states women: Prevalence and correlates. Obstet Gynecol. 2008;112:970–978.PubMedCrossRefGoogle Scholar
  4. 4.
    West SL, D’Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of us women. Arch Intern Med. 2008;168:1441–1449.PubMedCrossRefGoogle Scholar
  5. 5.
    Loeb TB, Williams JK, Carmona JV, et al. Child sexual abuse: Associations with the sexual functioning of adolescents and adults. Annu Rev Sex Res. 2002;13:307–345.PubMedGoogle Scholar
  6. 6.
    Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril. 2001;76:456–460.PubMedCrossRefGoogle Scholar
  7. 7.
    Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: A 9-year prospective population-based study. The melbourne women’s midlife health project. Climacteric. 2004;7:375–389.PubMedCrossRefGoogle Scholar
  8. 8.
    Al-Azzawi F, Bitzer J, Brandenburg U, et al. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric. 2010;13:103–120.PubMedCrossRefGoogle Scholar
  9. 9.
    Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13:S1–S4.PubMedCrossRefGoogle Scholar
  10. 10.
    Rellini AH, Meston CM. Sexual self-schemas, sexual dysfunction, and the sexual responses of women with a history of childhood sexual abuse. Arch Sex Behav. 2011;40:351–362.PubMedCrossRefGoogle Scholar
  11. 11.
    Heitkemper M, Jarrett M, Taylor P, Walker E, Landenburger K, Bond EF. Effect of sexual and physical abuse on symptom experiences in women with irritable bowel syndrome. Nurs Res. 2001;50:15–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Drossman DA, Camilleri M, Mayer EA, Whitehead WE. Aga technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131.PubMedCrossRefGoogle Scholar
  13. 13.
    Cain KC, Jarrett ME, Burr RL, Rosen S, Hertig VL, Heitkemper MM. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci. 2009;54:1542–1549.PubMedCrossRefGoogle Scholar
  14. 14.
    Shifren JL, Johannes CB, Monz BU, Russo PA, Bennett L, Rosen R. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt). 2009;18:461–468.CrossRefGoogle Scholar
  15. 15.
    Evangelia N, Kirana PS, Chiu G, Link C, Rosen R, Hatzichristou D. Level of bother and treatment-seeking predictors among male and female in-patients with sexual problems: A hospital-based study. J Sex Med. 2010;7:700–711.PubMedCrossRefGoogle Scholar
  16. 16.
    McGahuey CA, Gelenberg AJ, Laukes CA, et al. The arizona sexual experience scale (asex): Reliability and validity. J Sex Marital Ther. 2000;26:25–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Prevalence and impact of antidepressant-associated sexual dysfunction in three european countries: Replication in a cross-sectional patient survey. J Psychopharmacol. 2010;24:489–496.PubMedCrossRefGoogle Scholar
  18. 18.
    Lew-Starowicz M, Gellert R. The sexuality and quality of life of hemodialyzed patients–ased multicenter study. J Sex Med. 2009;6:1062–1071.PubMedCrossRefGoogle Scholar
  19. 19.
    Soykan A, Boztas H, Idilman R, et al. Sexual dysfunctions in hcv patients and its correlations with psychological and biological variables. Int J Impot Res. 2005;17:175–179.PubMedCrossRefGoogle Scholar
  20. 20.
    Gelenberg AJ, McGahuey C, Laukes C, et al. Mirtazapine substitution in ssri-induced sexual dysfunction. J Clin Psychiatry. 2000;61:356–360.PubMedCrossRefGoogle Scholar
  21. 21.
    Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–660.PubMedCrossRefGoogle Scholar
  22. 22.
    Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL: Cisapride for intestinal constipation. Cochrane Database Syst Rev. 2011:CD007780.Google Scholar
  23. 23.
    Schey R, Rao SS. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci. 2011;56:1619–1625.PubMedCrossRefGoogle Scholar
  24. 24.
    Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.PubMedCrossRefGoogle Scholar
  25. 25.
    Jarrett ME, Cain KC, Burr RL, Hertig VL, Rosen SN, Heitkemper MM. Comprehensive self-management for irritable bowel syndrome: Randomized trial of in-person vs. Combined in-person and telephone sessions. Am J Gastroenterol. 2009;104:3004–3014.PubMedCrossRefGoogle Scholar
  26. 26.
    Drossman D, Corazziari E, Talley N, Thompson W, Whitehead WE. Rome ii: the functional gastrointestinal disorders. McLean: Degnon Associates, Inc.; 2000.Google Scholar
  27. 27.
    Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1997;11:547–552.PubMedCrossRefGoogle Scholar
  28. 28.
    Derogatis L. Brief symptom inventory: Administration, scoring and procedures manual. 4th ed. Minneapolis: National Computer Systems; 1993.Google Scholar
  29. 29.
    Bernstein DP. Childhood trauma questionnaire. San Antonio: The Psychological Corporation; 1998.Google Scholar
  30. 30.
    Bernstein DP, Ahluvalia T, Pogge D, Handelsman L. Validity of the childhood trauma questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry. 1997;36:340–348.PubMedCrossRefGoogle Scholar
  31. 31.
    Buysse DJ, Reynolds CF 3rd. Monk TH, Berman SR, Kupfer DJ: The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.PubMedCrossRefGoogle Scholar
  32. 32.
    Guthrie E, Creed FH, Whorwell PJ. Severe sexual dysfunction in women with the irritable bowel syndrome: Comparison with inflammatory bowel disease and duodenal ulceration. Br Med J (Clin Res Ed). 1987;295:577–578.CrossRefGoogle Scholar
  33. 33.
    APA, ed. Diagnostic and statistical manual of mental disorders, text revision. 4th ed. Washington, DC: American Psychiatric Association; 2000.Google Scholar
  34. 34.
    Choung RS, Herrick LM, Locke GR III, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: A population-based study. J Clin Gastroenterol. 2010;44:696–701.PubMedGoogle Scholar
  35. 35.
    Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553–559.PubMedCrossRefGoogle Scholar
  36. 36.
    van den Brink M, Bandell-Hoekstra EN, Abu-Saad HH. The occurrence of recall bias in pediatric headache: A comparison of questionnaire and diary data. Headache. 2001;41:11–20.PubMedCrossRefGoogle Scholar
  37. 37.
    Lewandowski AS, Palermo TM, Kirchner HL, Drotar D. Comparing diary and retrospective reports of pain and activity restriction in children and adolescents with chronic pain conditions. The Clinical Journal of Pain. 2009;25:299–306.PubMedCrossRefGoogle Scholar
  38. 38.
    Niere K, Jerak A. Measurement of headache frequency, intensity and duration: Comparison of patient report by questionnaire and headache diary. Physiother Res Int. 2004;9:149–156.PubMedCrossRefGoogle Scholar
  39. 39.
    Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction. J Clin Psychiatry. 2001;62:10–21.PubMedGoogle Scholar
  40. 40.
    Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol. 2009;29:157–164.PubMedCrossRefGoogle Scholar
  41. 41.
    Yang JC, Park K, Eun SJ, et al. Assessment of cerebrocortical areas associated with sexual arousal in depressive women using functional mr imaging. J Sex Med. 2008;5:602–609.PubMedCrossRefGoogle Scholar
  42. 42.
    Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-analysis. Gut. 2009;58:367–378.PubMedCrossRefGoogle Scholar
  43. 43.
    Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 2000;61:276–281.PubMedCrossRefGoogle Scholar
  44. 44.
    Ashton AK, Mahmood A, Iqbal F. Improvements in ssri/snri-induced sexual dysfunction by switching to escitalopram. J Sex Marital Ther. 2005;31:257–262.PubMedCrossRefGoogle Scholar
  45. 45.
    Ozmenler NK, Karlidere T, Bozkurt A, et al. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol. 2008;23:321–326.PubMedCrossRefGoogle Scholar
  46. 46.
    Safarinejad MR. Reversal of ssri-induced female sexual dysfunction by adjunctive bupropion in menstruating women: A double-blind, placebo-controlled and randomized study. J Psychopharmacol. 2011;25:370–378.PubMedCrossRefGoogle Scholar
  47. 47.
    Bachmann G, Bobula J, Mirkin S. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy. Climacteric. 2010;13:132–140.PubMedCrossRefGoogle Scholar
  48. 48.
    Schwartz TL, Nasra GS, Ashton AK, et al. An open-label study to evaluate switching from an ssri or snri to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder. Ann Clin Psychiatry. 2007;19:25–30.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Margaret D. Eugenio
    • 1
  • Sang-Eun Jun
    • 2
  • Kevin C. Cain
    • 3
  • Monica E. Jarrett
    • 4
  • Margaret M. Heitkemper
    • 4
  1. 1.Department of Internal Medicine, Division of Gastroenterology, School of MedicineUniversity of WashingtonSeattleUSA
  2. 2.College of NursingKeimyung UniversityDalseo-qu, DaeguKorea
  3. 3.Department of Biostatistics, Office for Nursing ResearchUniversity of WashingtonSeattleUSA
  4. 4.Department of Biobehavioral Nursing and Health SystemsUniversity of WashingtonSeattleUSA

Personalised recommendations